Expansion Therapeutics
MA - WalthamBiotechnology
Focus: Expansion Therapeutics is a biotechnology company focused on developing small molecule therapeutics for RNA-mediated diseases, with a specialized platform targeting gene therapy indications. The company is early-stage with a single Phase 1 program and operates from Waltham, MA.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Expansion Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Expansion Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT03959189Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1
Phase 1Help build intelligence for Expansion Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.